Advanced search
Publication Cover
Cancer Biology & Therapy Volume 7, 2008 - Issue 5
Submit an article Journal homepage
345
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Inhibition of tumor growth and metastasis by ATF-Fc, an engineered antibody targeting urokinase receptor

Xian-wen Hu
,
Hai-feng Duan
,
Hai-feng Duan
,
Shu-yuan Pan
,
Yong-mei Li
,
Yongyi Xi
,
Su-Rong Zhao
,
Liang Yin
,
Jin-feng Li
,
Hui-Peng Chen
,
Chu-Tse Wu
&
Li-Hua Gao
 show all
Pages 651-659 | Published online: 01 Jun 2008

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Shih-Chi Su, Chiao-Wen Lin, Wei-En Yang, Wen-Lang Fan & Shun-Fa Yang. (2016) The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opinion on Therapeutic Targets 20:5, pages 551-566.
Read now
Xueliang Gao, Haizhen Wang, Jenny Yang & Zhi-Ren Liu. (2013) Prevent protein interactions to prevent cancer metastasis. Expert Review of Proteomics 10:3, pages 207-209.
Read now
Manfred Schmitt, Karin Mengele, Rudolf Napieralski, Viktor Magdolen, Ute Reuning, Apostolos Gkazepis, Fred Sweep, Nils Brünner, John Foekens & Nadia Harbeck. (2010) Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Review of Molecular Diagnostics 10:8, pages 1051-1067.
Read now
Ralf Hildenbrand, Heike Allgayer, Alexander Marx & Philipp Stroebel. (2010) Modulators of the urokinase-type plasminogen activation system for cancer. Expert Opinion on Investigational Drugs 19:5, pages 641-652.
Read now

Articles from other publishers (9)

Tianxiong Mi, Siriwalee Siriwibool & Kevin Burgess. (2023) Streamlined Protein‐Protein Interface Loop Mimicry. Angewandte Chemie International Edition 62:49.
Crossref
Tianxiong Mi, Siriwalee Siriwibool & Kevin Burgess. (2023) Streamlined Protein‐Protein Interface Loop Mimicry. Angewandte Chemie.
Crossref
Bing-Tao Zhai, Huan Tian, Jing Sun, Jun-Bo Zou, Xiao-Fei Zhang, Jiang-Xue Cheng, Ya-Jun Shi, Yu Fan & Dong-Yan Guo. (2022) Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer. Journal of Translational Medicine 20:1.
Crossref
Sofia C. Ramos, Augusto J. de Matos, Joao Niza Ribeiro, Liliana R. Leite-Martins, Rui R. F. Ferreira, Ines Viegas & Andreia A. Santos. (2017) Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients. Veterinary World 10:8, pages 918-923.
Crossref
P.A. van Dam, A. Coelho & C. Rolfo. (2017) Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?. European Journal of Surgical Oncology (EJSO) 43:2, pages 252-257.
Crossref
Kasper Almholt, Ole Didrik Lærum, Boye Schnack Nielsen, Ida Katrine Lund, Leif Røge Lund, John Rømer & Annika Jögi. (2015) Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR. Clinical & Experimental Metastasis 32:6, pages 543-554.
Crossref
Shafaat A. Rabbani, Bushra Ateeq, Ani Arakelian, Maria Luisa Valentino, David E. Shaw, Lisa M. Dauffenbach, Christopher A. Kerfoot & Andrew P. Mazar. (2010) An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo. Neoplasia 12:10, pages 778-788.
Crossref
Heike Allgayer. (2010) Translational research on u-PAR. European Journal of Cancer 46:7, pages 1241-1251.
Crossref
Andrew P. Mazar. (2008) Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy. Clinical Cancer Research 14:18, pages 5649-5655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.